S&P 500   3,849.62 (-0.15%)
DOW   30,937.04 (-0.07%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
S&P 500   3,849.62 (-0.15%)
DOW   30,937.04 (-0.07%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
S&P 500   3,849.62 (-0.15%)
DOW   30,937.04 (-0.07%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
S&P 500   3,849.62 (-0.15%)
DOW   30,937.04 (-0.07%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
Log in
OTCMKTS:COTQF

Cotinga Pharmaceuticals Earnings Date, Estimates & History

$0.30
0.00 (0.00 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.30
Now: $0.30
$0.44
50-Day Range
$0.03
MA: $0.14
$0.60
52-Week Range
$0.01
Now: $0.30
$0.95
Volume9,240 shs
Average Volume1,976 shs
Market Capitalization$6.60 million
P/E RatioN/A
Dividend YieldN/A
Beta43.44

Earnings

Cotinga Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 29th, 2021 based off prior year's report dates.

Cotinga Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Cotinga Pharmaceuticals (OTCMKTS COTQF) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
1/29/2021
(Estimated)
       
4/1/2020Q3 2020($0.02)($0.02)N/A
12/27/2019Q2 2020($0.02)($0.02)N/A
10/30/2019Q1 2020($0.02)($0.02)N/A
9/4/2019Q4 2019($0.03)($0.03)N/A
4/1/2019Q3 2019($0.01)($0.01)N/A
12/31/2018Q2 2019($0.02)($0.02)N/A
10/1/2018Q1 2019($0.03)($0.03)N/A
8/28/2018Q4 2018($0.08)($0.08)N/A
4/3/2018Q3 2018($0.11)($0.06)($0.06)N/A
12/29/2017Q2 2018($0.10)($0.09)($0.09)N/A
9/29/2017Q1 2018($0.02)($0.02)N/A
8/28/2017Q4 2017($0.10)($0.10)N/A
3/16/2017Q3 2017($0.10)($0.10)($0.10)N/A
12/19/2016Q2 2017($0.10)($0.10)($0.10)N/A
9/29/2016Q1 2017($0.10)($0.10)($0.10)N/A
8/3/2016Q4 2016($0.10)($0.10)N/A
3/11/2016Q3 2016($0.10)($0.10)N/A
12/16/2015Q2 2016($0.10)($0.10)N/A
9/29/2015Q1 2016($0.10)($0.10)N/A
8/28/2015Q4 2015($0.10)($0.10)N/A
3/20/2015Q3 2015($0.10)($0.10)N/A
12/18/2013Q3($0.01)Listen
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.